BPN319: Quantitative Study on Cancer Research: Aptasensor for Cancer Diagnostics


Early detection of cancer markers is a critical demand for clinical research, particularly in preventing cancer cells from establishing themselves in a metastatic stage. Our goal is to provide a stable, sensitive, and selective detection method utilizing a nanoplasmonic ‘aptasensor’ (aptamer-based sensor) of vascular endothelial growth factor (VEGF) for breast cancer diagnostics.

Project end date: 08/12/10

Charlie Yeh
Publication date: 
February 1, 2010
Publication type: 
BSAC Project Materials (Final/Archive)
PREPUBLICATION DATA - ©University of California 2010

*Only registered BSAC Industrial Members may view project materials & publications. Click here to request member-only access.